Srini Gopalan, T-Mobile's current COO, is set to step in as CEO on Nov. 1, 2025, taking over from Mike Sievert, just as the ...
It’s a man-only organization dedicated to ‘patriotism’, which is the new catch-all buzzword for white, Christian, ...
The FDA granted priority review for trastuzumab deruxtecan in combination with pertuzumab for first-line treatment of adults with unresectable or metastatic HER2-positive breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback